http://orcid.org/0000-0002-2451-3180
About the Authors
- Jos L. van der Velden
-
Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, United States of America
- John F. Alcorn
-
Roles Conceptualization, Writing – review & editing
Affiliation Children’s Hospital of Pittsburgh University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America
- David G. Chapman
-
Roles Data curation, Formal analysis, Methodology, Writing – review & editing
Affiliation Departments of Medicine, University of Vermont, Burlington, Vermont, United States of America
- Lennart K. A. Lundblad
-
Roles Formal analysis, Writing – review & editing
Affiliation Departments of Medicine, University of Vermont, Burlington, Vermont, United States of America
- Charles G. Irvin
-
Roles Supervision, Writing – review & editing
Affiliation Departments of Medicine, University of Vermont, Burlington, Vermont, United States of America
- Roger J. Davis
-
Roles Resources
Affiliation Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
- Kelly Butnor
-
Roles Formal analysis, Writing – original draft
Affiliation Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, United States of America
- Yvonne M. W. Janssen-Heininger
-
Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft
* E-mail: yvonne.janssen@uvm.edu
Affiliation Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vermont, United States of America
Competing Interests
The authors have read the journal's policy and have the following competing interests: Jos van der Velden and Yvonne Janssen-Heininger received $120000 from Celgene Corporation to test the impact of CC930 and CC90001 on house dust mite-induced fibrotic airway remodeling in mice. There are no patents, products in development or marketed products associated with this research to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.